MK Poulsen, JE Henriksen, O Hother-Nielsen, H … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Sixteen obese type 2 diabetic outpatients on human
NPH or MIX (regular + NPH insulin) insulin twice daily were randomized to either triple
therapy, ie, insulin aspart (a rapid-acting insulin analog) at meals, metformin (which ... Cited by 56 - Related articles - BL Direct - All 6 versions
[CITATION] No increase in the duration of action with rising doses of insulin aspart
N Ejskjaer, M Rasmussen, N Kamp, A … - Diabetes Obesity …, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 16 - Related articles - BL Direct - All 4 versions
[CITATION] Superior meal-time glucose control with insulin aspart (NovoLog) compared with …
- ►diabetesjournals.org RG Bretzel, S Arnolds, J Medding, T Linn - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 231 type 2 diabetic patients were randomized
to insulin aspart (n = 75), HI (n = 80), or MIX (n = 76) for 3 months. Insulin aspart and HI were
administered with or without bedtime NPH insulin. A total of 204 patients completed the ... Cited by 52 - Related articles - BL Direct - All 7 versions
H De Boer, M Jansen, J Koerts, L … - Diabetes Obesity and …, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 22 - Related articles - BL Direct - All 3 versions
[CITATION] Insulin aspart in paediatric patients with type 1 diabetes
